z-logo
open-access-imgOpen Access
Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol
Author(s) -
Jacek Staszewski,
Renata PiusińskaMacoch,
Ewa Skrobowska,
Bogdan Brodacki,
Rafał Pawlik,
Tomasz Dutkiewicz,
Wiesław Piechota,
Alicja Rączka,
Kazimierz Tomczykiewicz,
Adam Stȩpień
Publication year - 2013
Publication title -
neuroscience journal
Language(s) - English
Resource type - Journals
eISSN - 2314-4270
pISSN - 2314-4262
DOI - 10.1155/2013/424695
Subject(s) - medicine , hemodynamics , disease , radiological weapon , stroke (engine) , cardiology , neuropsychology , blood pressure , surgery , cognition , engineering , psychiatry , mechanical engineering
Rationale. This paper describes the rationale and design of the SHEF-CSVD Study, which aims to determine the long-term clinical and radiological course of cerebral small vessel disease (CSVD) and to evaluate haemostatic and haemodynamic prognostic factors of the condition. Design. This single-centre, prospective, non-interventional cohort study will follow 150 consecutive patients with different clinical manifestations of CSVD (lacunar ischaemic stroke, vascular dementia, vascular parkinsonism or spontaneous deep, intracerebral haemorrhage) and 50 age- and sex-matched controls over a period of 24 months. The clinical and radiological course will be evaluated basing on a detailed neurological, neuropsychological and MRI examinations. Haemodynamic (cerebral vasoreactivity, 24 h blood pressure control) and haemostatic factors (markers of endothelial and platelet dysfunction, brachial artery flow-mediated dilatation test) will be determined. Discussion. The scheduled study will specifically address the issue of haemodynamic and haemostatic prognostic factors and their course over time in various clinical manifestations of CSVD. The findings may aid the development of prophylactic strategies and individualised treatment plans, which are critical during the early stages of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom